PT Kalbe Farma Tbk
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PTKFY research report →
About the company
PT Kalbe Farma Tbk is engaged in the development, distribution, and trading of pharmaceutical products. It operates through the following divisions: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. The Prescription Pharmaceutical division offers generic drugs, branded generics, and licensed drugs, which are distributed to hospitals, pharmacies, and drug stores.
- CEO
- Bernadette Ruth Setiady
- IPO
- 2012
- Employees
- 12,835
- HQ
- Jakarta, JK, ID
Price Chart
- Market Cap
- $9.40M
- P/E
- 9.41
- P/S
- 0.94
- P/B
- 1.40
- EV/EBITDA
- 5.66
- Div Yield
- 2.67%
- Gross Margin
- 38.67%
- Op Margin
- 12.30%
- Net Margin
- 10.00%
- ROE
- 15.56%
- ROIC
- 13.15%
- Revenue
- $35.32T · 8.27%
- Net Income
- $3.66T · 13.10%
- EPS
- $16176.00 · 15.28%
- Op Income
- $4.55T
- FCF YoY
- -30.38%
- 52W High
- $19.50
- 52W Low
- $7.78
- 50D MA
- $9.40
- 200D MA
- $12.33
- Beta
- -0.04
- Avg Volume
- 208
Get TickerSpark's AI analysis on PTKFY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our PTKFY coverage
Recent articles, reports, and earnings notes.
No research on PTKFY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PTKFY report →Similar companies
Peers in the same neighborhood.